TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Stock
Equities
000766
CNE000000735
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.2 CNY | +9.62% |
|
-9.19% | -13.74% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 1.47B 204M | Sales 2023 | 1.47B 204M | Capitalization | 19.27B 2.67B |
|---|---|---|---|---|---|
| Net income 2022 | 30M 4.15M | Net income 2023 | 43M 5.95M | EV / Sales 2022 | 4.46 x |
| Net Debt 2022 | 1.46B 202M | Net Debt 2023 | 1.52B 211M | EV / Sales 2023 | 14.1 x |
| P/E ratio 2022 |
176
x | P/E ratio 2023 |
399
x | Employees | 1,696 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.69% |
More Fundamentals
* Assessed data
More news
| 1 day | +9.62% | ||
| 1 week | -9.19% | ||
| Current month | +0.23% | ||
| 1 month | +13.01% | ||
| 3 months | +27.41% | ||
| 6 months | +17.81% | ||
| Current year | -13.74% |
1 week
15.10
19.25
1 month
15.1019.85
Current year
12.1220.95
1 year
4.5324.51
3 years
3.6324.51
5 years
2.7824.51
10 years
2.7824.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Fu Zhang
CHM | Chairman | 62 | 19-09-15 |
Chang You Xu
CHM | Chairman | 57 | 10-12-31 |
Jun Yu
DFI | Director of Finance/CFO | 53 | 03-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Yu
DFI | Director of Finance/CFO | 53 | 03-12-31 |
Gui Xia Lü
BRD | Director/Board Member | 56 | 20-04-14 |
Chang You Xu
CHM | Chairman | 57 | 10-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 17.2 | +9.62% | 62,249,650 |
| 24-05-15 | 15.69 | -2.18% | 40,291,010 |
| 24-05-14 | 16.04 | -5.48% | 71,879,800 |
| 24-05-13 | 16.97 | -10.02% | 43,706,480 |
| 24-05-10 | 18.86 | -0.42% | 30,185,250 |
End-of-day quote Shenzhen S.E., May 15, 2024
More quotes
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main products consist of Chinese patent drugs, chemical drugs and bulk drugs, among others. The Companyâs products are used in anti-tumor, microbial, digestive system, skeletal and muscle system, gynecology, nervous system and other areas. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-19
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.74% | 2.3B | |
| +32.36% | 694B | |
| +29.71% | 593B | |
| -1.60% | 371B | |
| +20.07% | 331B | |
| +6.04% | 290B | |
| +14.42% | 239B | |
| -3.48% | 209B | |
| +10.05% | 209B | |
| +9.27% | 169B |
- Stock Market
- Equities
- 000766 Stock
